fluorodopa (18F)

VARIOUS

Key facts

fluorodopa (18F) is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 2019. Recorded indications include Positron emission tomography.

• Approval status: ofp (first approved 2019 by the FDA).
• Indications: Positron emission tomography.
• ATC code: V09IX05 (Other diagnostic radiopharmaceuticals for tumour detection).
• Molecular formula: C9H10FNO4; molecular weight 214.18 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Positron emission tomography

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2019-10-10	FDA	—	FEINSTEIN

ATC classification

ATC code	Therapeutic hierarchy
V09IX05	VARIOUS › DIAGNOSTIC RADIOPHARMACEUTICALS › TUMOUR DETECTION › Other diagnostic radiopharmaceuticals for tumour detection

Chemical structure

• Molecular formula: C₉H₁₀FNO₄
• Molecular weight: 214.18 g/mol
• CAS number: 92812-82-3
• InChIKey: PAXWQORCRCBOCU-RPDRGXCHSA-N
• PubChem CID: 56494

N[C@@H](CC1=C([18F])C=C(O)C(O)=C1)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is fluorodopa (18F) used for?

DrugCentral lists the following indications for fluorodopa (18F): Positron emission tomography.

When was fluorodopa (18F) first approved?

fluorodopa (18F) was first approved by the FDA in 2019.

What is the chemical formula of fluorodopa (18F)?

fluorodopa (18F) has the molecular formula C9H10FNO4 and a molecular weight of 214.18 g/mol.

Sources

• DrugCentral drug card 4550 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL3400972 — compound record and bioactivity
• PubChem CID 56494 — chemical identifiers
• DrugBank DB13848 — drug record
• FDA UNII 2C598205QX — substance identity
• DailyMed: FDA labels for fluorodopa (18F) — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.